Treatment of respiratory diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7368104
APP PUB NO 20050019271A1
SERIAL NO

10926196

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HEPTARES THERAPEUTICS LIMITEDCAMBRIDGE CB21 6DG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bannister, Robin Mark Essex, GB 64 689
Gilbert, Julian Clive Essex, GB 30 321
Morton, David A V Bath, GB 3 37
Richards, Andrew John McGlashan Cambridge, GB 20 238
Staniforth, John Bath, GB 29 612

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation